Strategic Alliance Management Conference

In today's fiercely competitive landscape, it's becoming increasingly important for Pharma organisations to strategically partner with each other and across the wider healthcare ecosystem. By doing so, they can leverage their strengths, share risks, and unlock innovation, resulting in benefits that far exceed the sum of the individual parts.

To fully realise the potential of strategic partnerships and maximise health outcomes, organisations must act now to change the way they operate, both at an enterprise and partnership level. 

Join our interactive session

Wednesday 12 June, 9.45am: Taking an Enterprise-Wide Perspective to Unlock the Full Potential of Strategic Partnerships

Strategic partnering is becoming more and more crucial in order to access the best innovation, share risk, and develop better integrated solutions for patients. Setting up your organisation's operating model with the intent of strategic partnering is key to its success. In this interactive session, Baringa's Josh Elliott talks with Steve Pessagno from GSK on their experiences on what needs to be considered at the enterprise-level in order to unlock successful partnering at the alliance level.

About Josh Elliott

Josh helps global BioPharma organisations navigate their most complex business transformations with his experience ranging from pre-clinical research through to commercialisation. His specialism and passion is in helping his BioPharma clients optimise how they strategically partner with the wider ecosystem to maximise outcomes, having advised multiple market-leading strategic alliances and helped set up partnering operating models for organisations as a whole.   Learn more about Josh